During allergic asthma, type 2 cytokines (particularly IL-4) induce high level IgE production by B cells that can then exert a systemic influence over granulocyte activation in the lung, for example through Fc receptor cross-linking and sensitisation of mast cells leading to heightened release of pathological mediators such as histamine. The gene discussed is IGHE; the disease is allergic asthma.